Belldegrun Arie
SEC CIK 1296549 · EDGAR
BoughtSold
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Belldegrun Arie made no open-market trades at ALLO in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-28 | 2025-01-24 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | A - Grant | $0.00 | +370.0K | 2.24M | +20% | $0 |
| D | 2024-06-14 | 2024-06-12 | DNA | Ginkgo Bioworks Holdings, Inc. | Belldegrun Arie | Dir | M - OptEx | — | +105.3K | 194.9K | +117% | — |
| I | 2024-05-20 | 2024-05-16 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | P - Purchase | $2.90 | +1.72M | 1.72M | New | +$5.00M |
| I | 2024-05-20 | 2024-05-16 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | A - Grant | $2.90 | +344.8K | 539.9K | +177% | +$1.00M |
| D | 2024-01-31 | 2024-01-25 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | A - Grant | $0.00 | +212.0K | 1.87M | +13% | $0 |
| D | 2023-03-24 | 2023-03-22 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | A - Grant | $0.00 | +1.28M | 1.65M | +345% | $0 |
| D | 2022-09-16 | 2022-09-14 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Dir | M - OptEx | $5.00 | +160.0K | 408.7K | +64% | +$800.0K |
| D | 2022-09-02 | 2022-08-31 | URGN | UroGen Pharma Ltd. | Belldegrun Arie | Dir | M - OptEx | $5.00 | +3,241 | 248.7K | +1% | +$16.2K |
| D | 2022-06-13 | 2022-06-10 | DNA | Ginkgo Bioworks Holdings, Inc. | Belldegrun Arie | Dir | A - Grant | $0.00 | +70.9K | 89.7K | +378% | $0 |
| MAI | 2022-04-01 | 2022-03-14 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | J - Other | $0.00 | 0 | 0 | New | $0 |
| MI | 2022-03-31 | 2022-03-14 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | J - Other | $0.00 | 0 | 0 | New | $0 |
| I | 2022-01-14 | 2022-01-12 | ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Dir | P - Purchase | $12.60 | +155.0K | 195.0K | +388% | +$1.95M |
Purchase Sale Sale after option exercise All abbreviations